Appointment of Ali Mortazavi as CEO
e-therapeutics plc (AIM: ETX, "e-therapeutics" or the "Company") today announces the appointment of Ali Mortazavi as Chief Executive Officer. He will also retain his position as Chairman of the Company. The Board currently consists of one Executive Director and two Non-Executive Directors.
Since his appointment in February, Ali has re-energised the Company and, importantly, played a significant role in restructuring the portfolio; including the establishment of a research programme on RNAi ...a key area for important new therapies for a number of major diseases. We are delighted that in addition to his role as Chairman he has accepted our invitation to lead the team as Chief Executive Officer.
Professor Trevor Jones CBE
Rarely does an opportunity arise to lead a company in an entirely new and burgeoning sector. I believe that e-therapeutics has established a key position among the small vanguard of companies across the globe applying computational biology to drug discovery. Our ambition is to take advantage of our momentum to become a major force at this intersection of technology and life sciences.
Executive Chairman and Chief Executive Officer